‘Faster, Better, More Efficient’ – Why Bayer Is Investing In ‘Precision Health’

22 Jun 2023

Bayer's head of R&D and chief scientific officer David Evendon-Challis talked to Medtech Insight about the company's prescision health business, including a holistic and personalized approach to digital self-care.

[Editor's Note: A version of this interview originally appeared in HBW Insight, Medtech Insight's sister publication dedicated to consumer health care.]

More than 80% of consumers globally want more personalized health care and want tools to help them predict and prevent...